Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $752.0900 (-1.21%) ($752.0900 - $761.9600) on Mon. May. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.59% (three month average) | RSI | 31 | Latest Price | $752.0900(-1.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.4% a day on average for past five trading days. | Weekly Trend | REGN declines -1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(46%) DIA(33%) VYM(32%) IWD(30%) | Factors Impacting REGN price | REGN will decline at least -0.795% in a week (0% probabilities). VXX(-28%) VIXM(-21%) TBT(-5%) UUP(-4%) ARKK(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.795% (StdDev 1.59%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $797.24 | 5 Day Moving Average | $773.96(-2.83%) | 10 Day Moving Average | $782.98(-3.95%) | 20 Day Moving Average | $797.24(-5.66%) | To recent high | -9.4% | To recent low | 2.1% | Market Cap | $79.743b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |